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Abstract
Purpose: The aim of the present study was to compare the anesthetic efficacy, and fetal and maternal effects of 7.5 mg 
(1 ml) intrathecal 0.75% hyperbaric ropivacaine + 25 μg (0.5 ml) fentanyl versus 5 mg (l ml) intrathecal 0.5% hyperbaric 
bupivacaine + 25 μg (0.5 ml) fentanyl in elective cesarean delivery.
Materials and Methods: The study included 40 ASA I–II cases scheduled for cesarean delivery that were randomized 
into two groups of 20 cases each. Cases in the RF group were administered 0.75% hyperbaric ropivacaine + 25 μg 
(0.5 ml) fentanyl and those in the BF group were administered 5 mg (l ml) hyperbaric bupivacaine + 25 μg (0.5 ml) 
fentanyl into the spinal space. The time until spinal anesthesia in the T4 dermatome, overall duration of analgesia, 
hemodynamic parameters, Apgar score of newborns at 1–5 min, fetal blood gas values (pH, PO2, PCO2, HCO3−, and 
BE), maternal side effects, the degree of motor block, maternal need for ephedrine, objective pain scale score, and 
patient satisfaction were recorded in each group.
Results: There were no significant differences between the groups in terms of the parameters evaluated (P  > 0.05).
Conclusion: In elective cesarean delivery, the combinations of bupivacaine + fentanyl or ropivacaine + fentanyl exhibited 
similar anesthetic efficacy, and fetal and maternal effects.
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Introduction
Anesthetic technique must produce adequate surgical 
anesthesia of adequate duration and minimal maternal 
and neonatal side effects during cesarean delivery. Spinal 
anesthesia provides a rapid and reliable anesthetic technique 
for cesarean section that may provide greater safety than 
general anesthesia. The principal side effects of spinal 
anesthesia for cesarean section are a reduction in maternal 
and uteroplacental blood flow/pressure, maternal pain,[1] and 
conversion to general anesthesia.[2] Reducing the dose of 
intrathecal local anesthetic (LA) will improve cardiovascular 
stability, but may not provide adequate surgical anesthesia. 
The addition of an opioid will allow the safe reduction of 
the LA dose with equal success and less severe side effects.[3]
There are many recommended combinations of LA/opioid 
for cesarean section spinal anesthesia. Ultra low doses 
such as 5 mg of bupivacaine with 25 µg of fentanyl have 
been reported to be adequate.[3] The addition of 0.15 mg 
of morphine[4] or 10 µg of fentanyl to 15 mg of hyperbaric 
ropivacaine produced good surgical anesthesia in all cases.
There are studies comparing the concentration and doses of 
the two drugs used epidurally in cesarean section or spinally 
in different surgeries.[5-7] We could not find any study with 
these doses used in cesarean section. So, that the aim of the 
present study was to compare the anesthetic efficacy, fetal 
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and maternal effects of 7.5 mg (1 ml) intrathecal 0.75% 
hyperbaric ropivacaine + 25 µg (0.5 ml) fentanyl versus 
5 mg (l ml) intrathecal 0.5% hyperbaric bupivacaine + 25 µg 
(0.5 ml) fentanyl in elective cesarean delivery.
Materials and Methods
The study included 40 ASA class I–II pregnant women 
aged 18–40 years. The study protocol was approved by our 
institution’s ethics committee. The study was randomized, 
double blind, and with two parallel treatment groups. 
Pregnant women who gave informed consent to an 
institutionally approved protocol were studied. Patients were 
not eligible if there was a history of allergy or sensitivity to 
amide-type LAs; maternal diabetes; a psychiatric history 
which could lead to unreliability in the clinical assessment; 
alcohol, drug, or medication abuse as judged by the 
investigator; or a contraindication for epidural procedures. 
Women who had hypotension and expectation of fetal 
anomaly, and those contraindicated for spinal anesthesia 
were excluded from the study.
Prior to spinal anesthesia, the women were placed in the 
10 degree–15 degree left lateral position in order to reduce 
aorta-caval pressure, and then 4 l/min of O2 was administered 
with a face mask and non-invasive arterial pressure, ECG, 
and peripheral oxygen saturation (SpO2) (Cato Edition 
Drager, Lubeck, Germany) monitoring were carried out. 
Before the spinal block, 15 ml/ kg/min of Ringer lactate 
solution was administered as bo.lus for 15 min and infusion 
was maintained at the rate of 8 ml/kg/h during the procedure. 
After prehydration infusion, the women were randomized 
into the RF group (n = 20) or BF group (n = 20) by random 
selection of envelops. While in a sitting position after 
antiseptic cleaning, the intrathecal region was entered from 
the L3–L4 space using a 26-G needle. After free CSF flow 
was observed, the RF group was administered 7.5 mg (1 ml) 
intrathecal 0.75% hyperbaric ropivacaine + 25 µg (0.5 ml) 
fentanyl, whereas the BF group was administered 5 mg (1 ml) 
0.5% hyperbaric bupivacaine + fentanyl 25 µg (0.5 ml). 
When sensorial block reached the T4 dermatome, the surgical 
procedure was initiated. The time to reach sensorial block 
to the T4 dermatome was determined by the pin-prick test.
Heart rate (HR), mean arterial pressure (MAP), and 
oxygen saturation (SpO2) were recorded before and 
after block, every 5 min during the perioperative period, 
and every 10 min during the postoperative period until 
analgesia was required. HR below 60 bpm was considered 
bradycardia and a decrease of >30% in MAP, as compared 
to the preoperative value, was considered hypotension. For 
bradycardia, i.v. atropine sulfate 0.5 mg was administered, 
and fluid replacement (colloid) was done and ephedrine 
(when necessary) was administered for hypotension. In 
the patients with slight pain of l degree–2 degree, analgesia 
was given with support. In both groups after babies 
were delivered, 20 units of oxytocin was administered 
intravenously. Additionally, 10–20 units of oxytocin was 
added to each liter of fluid. Blood samples (2 ml) were 
obtained from the umbilical artery. Blood gas analysis was 
carried out on the samples using a Stat Profile 9 device 
(Nova, USA).
Overall duration of analgesia, the degree of motor block 
(measured with a Bromage scale) at 5-min intervals, 
objective pain scale score at 10-min intervals (0: Perfect; 
l: Good; 2: Moderate; 3: Inadequate; 4: Poor-bad), and 
patient satisfaction with the method (l: Very good; 2: Good; 
3: Bad; 4: I will never use it) were recorded. Apgar scores 
of the newborns were recorded at 1 and 5 min, maternal 
side effects (headache, tinnitus, bradycardia, hypotension, 
respiratory depression, nausea and vomiting, itching and 
urticaria, and head, arm, and chest pain) were evaluated 
every 5 min, and the dose of ephedrine used and the time 
until the first need of analgesics were recorded. An Apgar 
score >7 at 1 and 5 min suggests that the methods do not 
have any adverse effects on the fetus.
The sample size for the study was calculated with the aim 
of showing a difference between treatments in duration of 
motor block, with a mean difference of at least 1 h. The 
standard deviation of Bromage 1 motor block was assumed 
to be approximately 1.1 h with 20 patients in each group 
and using a significance level of 0.05.
SPSS for Windows v. 11.0 was used for statistical evaluation 
of the data obtained. To evaluate the data, in addition to 
descriptive statistical methods (frequency, mean, and standard 
deviation), following the analysis of the distribution of 
parameters using the Kolmogorov Smirnov test, the t test was 
used for data distributed normally in independent groups and 
the Mann–Whitney U test was used for groups in which data 
were not distributed normally. The significance of differences 
in time was investigated using the t test in dependent groups. 
Correlation coefficients were used to investigate relationships. 
Results were evaluated at 95% confidence interval and 
P values <0.05 were considered significant.
Results
There were no statistically significant differences in 
demographic data between the two groups (P > 0.05) 
[Table 1]. The time for analgesia to reach the T4 dermatome 
and the overall duration of analgesia were not statistically 
significant (P > 0.05) [Table 1].
Table 2 shows the Apgar scores at 1 and 5 min in each 
group. A significant difference was not observed between the 
groups with regard to 1- and 5-min Apgar scores (P > 0.05).
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Table 3 shows that the fetus delivery time and duration of 
the procedure in both groups were not significantly different 
(P > 0.05).
Fetal blood gas values in both groups are shown in Table 4. 
There were no statistically significant differences between 
the groups (P > 0.05).
The degree of motor block difference was not statistically 
significant (P > 0.05) [Table 5].
According to the objective pain scale scores, 5 (25%) cases 
in the RF group and 7 (35%) cases in the BF group did not 
have pain. In addition, 15 (75%) cases in the RF group 
and 13 (65%) cases in the BF group complained of slight 
pain (1 degree–2 degree) that support with sedoanalgesia 
[Table 6]. Table 7 shows the patient satisfaction with the 
method in both groups; the difference was not statistically 
significant (P > 0.05).
Regarding hemodynamic parameters, within 10 min of 
spinal block in the RF group, 3 (10%) cases had bradycardia 
that responded to atropine and 8 had (16.6%) hypotension 
that was corrected with fluid replacement. In the BF group, 
2 (6.6%) cases had bradycardia (they also had concurrent 
hypotension) and responded to atropine + fluid replacement, 
and in 9 cases (16.6%) only hypotension was observed. 
A significant difference between the groups in terms of 
atropine and ephedrine doses was not observed (P > 0.05), 
nor was there a difference in SpO2 values (P > 0.05).
Respiratory depression and tinnitus did not occur in 
either group. Nausea was observed in 12 patients in the 
RF group and in 13 patients in the BF group. In the RF 
group, 3 patients had bradycardia coexisting with nausea 
and responded to atropine. In the BF group, nausea was 
accompanied by bradycardia and hypotension in six 
patients that responded to atropine + fluid replacement. 
A significant difference between the groups in terms of 
maternal side effects was not observed (P > 0.05) [Table 8].
Discussion
There were no statistically significant differences in 
demographic data, the time for analgesia to reach the 
T4 dermatome, the overall duration of analgesia, 1- and 
5-min Apgar scores, fetus delivery time, duration of the 
procedure, fetal blood gas values, and the degree of motor 
block between the two groups.
Ideal intrathecal anesthesia for cesarean section is characterized 
by localized effect, minimal impact on motor function, effect 
at low doses, minimal maternal and fetal side effects, and 
reversibility.[8] From prospective trials, it is clear that lowering 
the spinal dose improves maternal hemodynamic stability. 
Doses of intrathecal bupivacaine between 5 and 7 mg are 













1 4 (20.0) 2 (10.0) >0.05
2 15 (85.0) 15 (75.0) >0.05
3 1 (5.0) 3 (15.0) >0.05












0 (perfect) 5 (25) 7 (35) >0.05
1 (moderate) 14 (70) 13 (65) >0.05
2 (inadequate) 1 (5) - >0.05
3 (poor) - - -






Fetus delivery time (min) 7.7 ± 1.7 7.7 ± 2 0.52
Duration of procedure (min) 43.5 ± 4.8 43.9 ± 5.3 0.51
Values are given as mean ± SD
Table 4: Fetal blood gas values
RF group (n = 20) BF group (n = 20) P
pH 7.4 ± 0.03 7.3 ± 0.02 0.07
PCO
2
 (mmHg) 39.2 ± 4.9 41.5 ± 1.1 0.27
PO
2 
(mmHg) 27.4 ± 6.1 25.8 ± 5.2 0.32
HCO
3
− (mEq/l) 24.5 ± 2.3 25.5 ± 2.8 0.14
BE_B (mEq/l) 0.88 ± 1.6 0.4 ± 2.21 0.38
Values are given as mean ± SD
Table 1: Demographic data and the duration of 
analgesia





Age (years) 30.5 ± 5.2 28.8 ± 5.2 0.61
Weight (kg) 66.76 ± 10.7 63.0 ± 8.6 >0.05
Length (cm) 159.8 ± 4.4 160.3 ± 4.6 >0.05
Pregnancy week 38.9 ± 1 38.4 ± 0.6 0.07
Birth weight (g) 3411.9 ± 361.5 3358.4 ± 482.7 0.65
Time to reach T4 
dermatome (min)
4.8 ± 1.1 5.00 ± 1.0 >0.05
Overall duration 
of analgesia (min)
138.5 ± 12.7 140.4 ± 29.2 >0.05
Values are given as mean ± SD P < 0.05 is significant
Table 2: Apgar scores at 1 and 5 min
RF group (n = 20) BF group (n = 20) P
1-min score 8.4 ± 0.5 8.1 ± 0.8 0.45
5-min score 9.7 ± 0.43 9.8 ± 0.3 0.49
Values are given as mean ± SD
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sufficient to provide effective anesthesia. Complete motor 
block is, however, seldom achieved and adequate anesthesia 
is limited in time.[8] Gaffud et al.[9] reported that for birth 
analgesia, the combination of bupivacaine + fentanyl yielded 
better analgesia than bupivacaine alone.[9] It was reported 
that the combined use of both drugs provides more rapid 
and prolonged anesthesia.[9] Fifteen milligrams of hyperbaric 
ropivacaine would seem a reasonable intrathecal dose for 
cesarean section. Intrathecal fentanyl (10–25 µg) may 
provide the best combination of minimal side effects, effective 
reduction in LA dose, and duration of action.
Different findings have been reported from minimum 
effective LA dose (MLAD) studies.[10] Several studies 
have been designed in order to find the optimum dosage of 
intrathecal LAs for obstetric patients. The MLAD model 
has been used in the investigation of analgesic requirements 
in labor. There are a few studies about the use of MLAD 
model in cesarean section.[11] In a study, it was concluded 
that the addition of sufentanil reduced the MLAD of both 
the LAs.[12] In this study, we observed that with the addition 
of fentanyl, doses of both LAs could be decreased. Further 
studies concerning this issue can be done.
Bogra et al.[13] administered bupivacaine at different doses for 
spinal anesthesia and reported that the rate of the decrease 
in systolic arterial blood pressure (SAP) correlated with the 
dose increase and became more marked with the addition of 
fentanyl to bupivacaine. Considering that  administration 
of LA also influences the development of hypotension. 
Knudsen[14] reported that ropivacaine does not have a 
marked effect on the cardiovascular system, which may be 
related to its partial vasoconstrictor effect. Likewise, in the 
present study, keeping the dose of local analgesics as low 
as possible and administering them at a low rate minimized 
the hemodynamic side effects. We feel that the hypotension 
and bradycardia observed in the present study may have 
been due to the adverse effect of LAs on the afferent 
conduction system of the heart at the T4 dermatome level, 
and that sympathetic block and bradycardia may have been 
associated with the effect of the LA causing sympathetic 
block. The data of hemodynamic properties obtained in the 
present study are consistent with those previously reported.
In studies on cesarean section where epidural ropivacaine 
has been compared to bupivacaine, most have used 
0.5% solutions in similar doses and found them 
equally effective.[15,16] Veneziani and colleagues[17] have 
compared ropivacaine 0.75% with bupivacaine 0.5%. They 
found ropivacaine 0.75% with fentanyl clinically superior 
to bupivacaine 0.5% with fentanyl using similar volumes 
(and consequently a 50% increase in dose).[17] Bjornestadt 
and colleagues[18] found plain ropivacaine 0.75% equally 
effective as bupivacaine 0.5%, but with a 50% increase in 
the dose of ropivacaine. Both 0.5% and 0.75% ropivacaine 
appear to be effective solutions for providing epidural 
anesthesia for cesarean section. Christelis et al.[5] found 
that epidural 0.75 % ropivacaine may be used as an 
alternative to 0.5% bupivacaine + fentanyl for elective 
cesarean delivery. In this study, the effectiveness of LA 
used spinally at that concentration was evaluated. Similar 
results were observed in studies conducted with epidural 
route.
In this study, the concentration of the LA was different, 
but the volume given to the patient was the same. Spread 
of intrathecal LAs is determined principally by baricity and 
position of the patient.[19] McLeod et al. determined the 
density of bupivacaine, levobupivacaine, and ropivacaine 
with and without dextrose at both 23°C and 37°C. They 
concluded that opioids such as fentanyl are hypobaric 
(0.9933 mg/ml) and when added to an LA will render the 
subsequent mixture even more hypobaric. The degree to 
which this occurs is proportional to the respective densities 
and volumes of individual drugs.[19] Although changes in 
density may seem minimal and clinically unnecessary, a 
change in density as low as 0.0006 mg/ml may influence 
the spread of LA.[10,19] The baricity of the drugs was not 
evaluated in this study. But we chose hyperbaric LA 
solutions. We conclude that baricity studies with this 
concentration and doses can be performed.
Due to low-level sensorial block in cases that were 
administered excessive ephedrine, some cases were 














1 (very good) 13 (65) 12 (60) >0.05
2 (good) 5 (25) 6(30) >0.05
3 (bad) 1 (5) 1 (5) >0.05
4 (will never use it again) 1 (5) 1 (5) >0.05
Table 8: Maternal side effects
Side effects RF group 








Bradycardia 3 (10) 2 (6.6) >0.05







Head, arm, and 
chest pain 
2 (6.6) 3 (10) >0.05
Tinnitus None None -
Nausea and 
vomiting
12 (40) 13 (43) >0.05
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administered additional LA from the epidural space; 
therefore, the increase in ephedrine use was attributed to 
additional administration of LA.[20,21] In the present study, 
ephedrine use was similar in both groups.
As in the present study, Ogun et al.[4] administered 
bupivacaine and ropivacaine at equal doses (morphine 
added) and observed that both agents had similar potency, 
in terms of sensorial block and postoperative analgesia.
A study concluded that sufficient anesthesia for cesarean 
delivery as a dose that provided adequate sensory 
dermatomal anesthesia to pinprick to T7 dermatome.[10] 
For cesarean delivery, it has been purposed that to achieve 
optimum conditions for surgery, one should aim to achieve 
an upper level of sensory anesthesia of T4.[22] But in a 
previous study, T7 was found to be the optimum anesthesia 
level which could provide good condition for cesarean 
section and higher block height probably resulted in the 
increased incidence of hypotension.[23,24] However, in many 
studies, though recording sensory block to T6, patients still 
have a significant incidence of visceral pain when using 
lower doses, especially when opioids are not added.
In this study, when sensory block reached the T4 dermatome, 
the surgical procedure was initiated. Pain usually occurred 
when the fetus was removed and patients mostly described 
chest pain, which was thought to be due to the stimulation of 
T4 sympathetic fibers related to stretching the peritoneum. 
None of the cases experienced 3 degree pain and, as such, 
did not receive general anesthesia. It shows that the sensory 
level is lower than T4 for the women to report pain due to 
peritoneal irritation. The uterus exteriorized during repair 
in this study. It may have caused pain.
In elective cesarean delivery, a lower degree of motor 
block with intrathecal anesthesia is desirable. Ogun et al. 
reported that motor block was longer in the bupivacaine 
group. Similarly, in the present study, motor block duration 
was longer in the BF group than in the RF group, but the 
difference was not statistically significant. Differences in the 
reported results may stem from differences in drug dosage 
and rate of administration, or differences in the additional 
opioids used.
Nausea in patients was attributed to stimulation of the 
chemoreceptor trigger zone caused by opioids, as well as to 
hypotension.[25] Itching and urticaria were reported to be 
due to the histamine-releasing effect of opioid drugs. [25] We 
think that side effects such as nausea, itching, and urticaria 
that occurred in the present study developed by the same 
mechanism.
Transfer of drugs to the placenta in general and regional 
anesthesia influences the fetus directly. Maternal hypotension 
and vasoconstrictive drugs may lead to fetal hypoxia and 
acidosis.[26] Intrathecal administration of opioids (i.e. spinal 
analgesia) has evolved from an experimental model into an 
important therapy for obstetric analgesia and anesthesia. 
A small dose of opioid delivered into the CSF provides 
almost immediate relief from labor pain with minimal risks to 
the mother and fetus.[27] Apgar scores and blood gas findings 
were within the normal range in the present study, which 
is consistent with the data reported in the literature. It is 
known that intrathecal anesthetic administration can give 
rise to headache, urinary retention, tinnitus, cauda equina 
syndrome, and transient neurological syndrome (TNS), 
depending on the diameter of the caudal needle used.[28] 
In this study, these side effects were not found.
In conclusion, in view of the fact that intrathecally administered 
bupivacaine + fentanyl or ropivacaine + fentanyl 
combinations prolonged the duration of postoperative 
analgesia and were comfortable for the patients during 
the perioperative and postoperative periods, and that 
there was a high level of patient satisfaction, we feel that 
both combinations of drugs have similar effects in elective 
cesarean delivery.
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A free application to browse and search the journal’s content is now available for iPhone/iPad. 
The application provides “Table of Contents” of the latest issues, which are stored on the device 
for future offline browsing. Internet connection is required to access the back issues and search 
facility. The application is Compatible with iPhone, iPod touch, and iPad and Requires iOS 3.1 or 
later. The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/
id458064375?ls=1&mt=8. For suggestions and comments do write back to us.
